Longevity Acquisition Stock Price, News & Analysis
LOAC
NASDAQ
Company Description
Longevity Acquisition (NASDAQ: LOAC) is a publicly traded company.
LOAC stock has gained 30.0% over the past year.
This page provides a comprehensive overview of LOAC stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
$—
0.00%
0.00
Last updated:
+29.99%
Performance 1 year
$0.0
2.6M
Longevity Acquisition (LOAC) stock. Over the past 12 months, the stock has gained 30.0%.
Latest News
Longevity Acquisition has 8 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 3 with negative movement. Key topics include acquisition, clinical trial. View all LOAC news →
SEC Filings
Financial Highlights
—
Revenue (TTM)
—
Net Income (TTM)
—
Operating Cash Flow
Upcoming Events
Short Interest History
Last 12 Months
Days to Cover History
Last 12 Months